Global Anti-D Immunoglobulin Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Intramuscular Anti-D Immunoglobulin, and Intravenous Anti-D Immunoglobulin), By Application (Hemolytic Disease of the Newborn (HDN), Rh Immunoprophylaxis During Pregnancy, and Management of Thrombocytopenic Patients), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035.

Industry: Healthcare
RELEASE DATE Jul 2025
REPORT ID SI13969
PAGES 200
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis, By Product Type
      2. Market Attractiveness Analysis, By Application
      3. Market Attractiveness Analysis, By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Rising awareness of hemolytic disease of the fetus and newborn (HDFN) and increasing childbirth rates
    3. Restraints
      1. High cost of Anti-D immunoglobulin and limited access in low-income regions
    4. Opportunities
      1.  Expansion in emerging markets and investment in R&D for improved formulations and delivery methods
    5. Challenges
      1. Limited plasma supply and stringent regulatory requirements
  6. Global Anti-D Immunoglobulin Market Analysis and Projection, By Product Type
    1. Segment Overview
    2. Intramuscular Anti-D Immunoglobulin
    3. Intravenous Anti-D Immunoglobulin
  7. Global Anti-D Immunoglobulin Market Analysis and Projection, By Application
    1. Segment Overview
    2. Hemolytic Disease of the Newborn (HDN)
    3. Rh Immunoprophylaxis during Pregnancy
    4. Management of Thrombocytopenic Patients
  8. Global Anti-D Immunoglobulin Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global Anti-D Immunoglobulin Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Anti-D Immunoglobulin Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. Grifols
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Bayer 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  CSL Behring 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Saol Therapeutics 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Octapharma 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Kedrion Biopharma
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Emergent BioSolutions
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Bio Products Laboratory
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Kamada Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Others 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Anti-D Immunoglobulin Market, By Product Type, 2024-2035(USD Billion)
  2. Global Intramuscular Anti-D Immunoglobulin, Anti-D Immunoglobulin Market, By Region, 2024-2035(USD Billion)
  3. Global Intravenous Anti-D Immunoglobulin, Anti-D Immunoglobulin Market, By Region, 2024-2035(USD Billion)
  4. Global Anti-D Immunoglobulin Market, By Application, 2024-2035(USD Billion)
  5. Global Hemolytic Disease of the Newborn (HDN), Anti-D Immunoglobulin Market, By Region, 2024-2035(USD Billion)
  6. Global Rh Immunoprophylaxis during Pregnancy, Anti-D Immunoglobulin Market, By Region, 2024-2035(USD Billion)
  7. Global Management of Thrombocytopenic Patients, Anti-D Immunoglobulin Market, By Region, 2024-2035(USD Billion)
  8. North America Anti-D Immunoglobulin Market, By Product Type, 2024-2035(USD Billion)
  9. North America Anti-D Immunoglobulin Market, By Application, 2024-2035(USD Billion)
  10. U.S.  Anti-D Immunoglobulin Market, By Product Type, 2024-2035(USD Billion)
  11. U.S.  Anti-D Immunoglobulin Market, By Application, 2024-2035(USD Billion)
  12. Canada Anti-D Immunoglobulin Market, By Product Type, 2024-2035(USD Billion)
  13. Canada Anti-D Immunoglobulin Market, By Application, 2024-2035(USD Billion)
  14. Mexico Anti-D Immunoglobulin Market, By Product Type, 2024-2035(USD Billion)
  15. Mexico Anti-D Immunoglobulin Market, By Application, 2024-2035(USD Billion)
  16. Europe Anti-D Immunoglobulin Market, By Product Type, 2024-2035(USD Billion)
  17. Europe Anti-D Immunoglobulin Market, By Application, 2024-2035(USD Billion)
  18. Germany Anti-D Immunoglobulin Market, By Product Type, 2024-2035(USD Billion)
  19. Germany Anti-D Immunoglobulin Market, By Application, 2024-2035(USD Billion)
  20. France Anti-D Immunoglobulin Market, By Product Type, 2024-2035(USD Billion)
  21. France Anti-D Immunoglobulin Market, By Application, 2024-2035(USD Billion)
  22. U.K.  Anti-D Immunoglobulin Market, By Product Type, 2024-2035(USD Billion)
  23. U.K.  Anti-D Immunoglobulin Market, By Application, 2024-2035(USD Billion)
  24. Italy Anti-D Immunoglobulin Market, By Product Type, 2024-2035(USD Billion)
  25. Italy Anti-D Immunoglobulin Market, By Application, 2024-2035(USD Billion)
  26. Spain Anti-D Immunoglobulin Market, By Product Type, 2024-2035(USD Billion)
  27. Spain Anti-D Immunoglobulin Market, By Application, 2024-2035(USD Billion)
  28. Asia Pacific Anti-D Immunoglobulin Market, By Product Type, 2024-2035(USD Billion)
  29. Asia Pacific Anti-D Immunoglobulin Market, By Application, 2024-2035(USD Billion)
  30. Japan Anti-D Immunoglobulin Market, By Product Type, 2024-2035(USD Billion)
  31. Japan Anti-D Immunoglobulin Market, By Application, 2024-2035(USD Billion)
  32. China Anti-D Immunoglobulin Market, By Product Type, 2024-2035(USD Billion)
  33. China Anti-D Immunoglobulin Market, By Application, 2024-2035(USD Billion)
  34. India Anti-D Immunoglobulin Market, By Product Type, 2024-2035(USD Billion)
  35. India Anti-D Immunoglobulin Market, By Application, 2024-2035(USD Billion)
  36. South America Anti-D Immunoglobulin Market, By Product Type, 2024-2035(USD Billion)
  37. South America Anti-D Immunoglobulin Market, By Application, 2024-2035(USD Billion)
  38. Brazil Anti-D Immunoglobulin Market, By Product Type, 2024-2035(USD Billion)
  39. Brazil Anti-D Immunoglobulin Market, By Application, 2024-2035(USD Billion)
  40. The Middle East and Africa Anti-D Immunoglobulin Market, By Product Type, 2024-2035(USD   Billion)
  41. The Middle East and Africa Anti-D Immunoglobulin Market, By Application, 2024-2035(USD   Billion)
  42. UAE Anti-D Immunoglobulin Market, By Product Type, 2024-2035(USD Billion)
  43. UAE Anti-D Immunoglobulin Market, By Application, 2024-2035(USD Billion)
  44. South Africa Anti-D Immunoglobulin Market, By Product Type, 2024-2035(USD Billion)
  45. South Africa Anti-D Immunoglobulin Market, By Application, 2024-2035(USD Billion)

 

List of Figures 

  1. Global Anti-D Immunoglobulin Market Segmentation
  2. Anti-D Immunoglobulin Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Anti-D Immunoglobulin Market
  9. Top Winning Strategies, 2024-2035
  10. Top Winning Strategies, By Development, 2024-2035(%)
  11. Top Winning Strategies, By Company, 2024-2035
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Anti-D Immunoglobulin Market
  20. Anti-D Immunoglobulin Market Segmentation, By Product Type
  21. Anti-D Immunoglobulin Market For Intramuscular Anti-D Immunoglobulin, By Region, 2024-2035 ($ Billion)
  22.  Anti-D Immunoglobulin Market For Intravenous Anti-D Immunoglobulin, By Region, 2024-2035 ($ Billion)
  23.  Anti-D Immunoglobulin Market Segmentation, By Application
  24.  Anti-D Immunoglobulin Market For Hemolytic Disease of the Newborn (HDN), By Region, 2024-2035 ($ Billion)
  25.  Anti-D Immunoglobulin Market For Rh Immunoprophylaxis during Pregnancy, By Region, 2024-2035 ($ Billion)
  26. Anti-D Immunoglobulin Market For Management of Thrombocytopenic Patients, By Region, 2024-2035 ($ Billion)
  27. Grifols: Net Sales, 2024-2035 ($ Billion)
  28. Grifols: Revenue Share, By Segment, 2024 (%)
  29. Grifols: Revenue Share, By Region, 2024 (%)
  30. Bayer: Net Sales, 2024-2035 ($ Billion)
  31. Bayer: Revenue Share, By Segment, 2024 (%)
  32. Bayer: Revenue Share, By Region, 2024 (%)
  33. CSL Behring: Net Sales, 2024-2035 ($ Billion)
  34. CSL Behring: Revenue Share, By Segment, 2024 (%)
  35. CSL Behring: Revenue Share, By Region, 2024 (%)
  36. Saol Therapeutics: Net Sales, 2024-2035 ($ Billion)
  37. Saol Therapeutics: Revenue Share, By Segment, 2024 (%)
  38. Saol Therapeutics: Revenue Share, By Region, 2024 (%)
  39. Octapharma: Net Sales, 2024-2035 ($ Billion)
  40. Octapharma: Revenue Share, By Segment, 2024 (%)
  41. Octapharma: Revenue Share, By Region, 2024 (%)
  42. Kedrion Biopharma: Net Sales, 2024-2035 ($ Billion)
  43. Kedrion Biopharma: Revenue Share, By Segment, 2024 (%)
  44. Kedrion Biopharma: Revenue Share, By Region, 2024 (%)
  45. Emergent BioSolutions: Net Sales, 2024-2035 ($ Billion)
  46. Emergent BioSolutions: Revenue Share, By Segment, 2024 (%)
  47. Emergent BioSolutions: Revenue Share, By Region, 2024 (%)
  48. Bio Products Laboratory: Net Sales, 2024-2035 ($ Billion)
  49. Bio Products Laboratory: Revenue Share, By Segment, 2024 (%)
  50. Bio Products Laboratory: Revenue Share, By Region, 2024 (%)
  51. Kamada Pharmaceuticals.: Net Sales, 2024-2035 ($ Billion)
  52. Kamada Pharmaceuticals.: Revenue Share, By Segment, 2024 (%)
  53. Kamada Pharmaceuticals.: Revenue Share, By Region, 2024 (%)
  54. Others: Net Sales, 2024-2035 ($ Billion)
  55. Others: Revenue Share, By Segment, 2024 (%)
  56. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2024
Tables & Figures:95
Pages:200
Countries covered:17
Companies covered::20
Forecast CAGR:5.46%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies